Cargando…
Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
Tissue Phenomics is the discipline of mining tissue images to identify patterns that are related to clinical outcome providing potential prognostic and predictive value. This involves the discovery process from assay development, image analysis, and data mining to the final interpretation and valida...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849604/ https://www.ncbi.nlm.nih.gov/pubmed/29535336 http://dx.doi.org/10.1038/s41598-018-22564-7 |
_version_ | 1783306065455087616 |
---|---|
author | Harder, Nathalie Athelogou, Maria Hessel, Harald Brieu, Nicolas Yigitsoy, Mehmet Zimmermann, Johannes Baatz, Martin Buchner, Alexander Stief, Christian G. Kirchner, Thomas Binnig, Gerd Schmidt, Günter Huss, Ralf |
author_facet | Harder, Nathalie Athelogou, Maria Hessel, Harald Brieu, Nicolas Yigitsoy, Mehmet Zimmermann, Johannes Baatz, Martin Buchner, Alexander Stief, Christian G. Kirchner, Thomas Binnig, Gerd Schmidt, Günter Huss, Ralf |
author_sort | Harder, Nathalie |
collection | PubMed |
description | Tissue Phenomics is the discipline of mining tissue images to identify patterns that are related to clinical outcome providing potential prognostic and predictive value. This involves the discovery process from assay development, image analysis, and data mining to the final interpretation and validation of the findings. Importantly, this process is not linear but allows backward steps and optimization loops over multiple sub-processes. We provide a detailed description of the Tissue Phenomics methodology while exemplifying each step on the application of prostate cancer recurrence prediction. In particular, we automatically identified tissue-based biomarkers having significant prognostic value for low- and intermediate-risk prostate cancer patients (Gleason scores 6–7b) after radical prostatectomy. We found that promising phenes were related to CD8(+) and CD68(+) cells in the microenvironment of cancerous glands in combination with the local micro-vascularization. Recurrence prediction based on the selected phenes yielded accuracies up to 83% thereby clearly outperforming prediction based on the Gleason score. Moreover, we compared different machine learning algorithms to combine the most relevant phenes resulting in increased accuracies of 88% for tumor progression prediction. These findings will be of potential use for future prognostic tests for prostate cancer patients and provide a proof-of-principle of the Tissue Phenomics approach. |
format | Online Article Text |
id | pubmed-5849604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-58496042018-03-21 Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer Harder, Nathalie Athelogou, Maria Hessel, Harald Brieu, Nicolas Yigitsoy, Mehmet Zimmermann, Johannes Baatz, Martin Buchner, Alexander Stief, Christian G. Kirchner, Thomas Binnig, Gerd Schmidt, Günter Huss, Ralf Sci Rep Article Tissue Phenomics is the discipline of mining tissue images to identify patterns that are related to clinical outcome providing potential prognostic and predictive value. This involves the discovery process from assay development, image analysis, and data mining to the final interpretation and validation of the findings. Importantly, this process is not linear but allows backward steps and optimization loops over multiple sub-processes. We provide a detailed description of the Tissue Phenomics methodology while exemplifying each step on the application of prostate cancer recurrence prediction. In particular, we automatically identified tissue-based biomarkers having significant prognostic value for low- and intermediate-risk prostate cancer patients (Gleason scores 6–7b) after radical prostatectomy. We found that promising phenes were related to CD8(+) and CD68(+) cells in the microenvironment of cancerous glands in combination with the local micro-vascularization. Recurrence prediction based on the selected phenes yielded accuracies up to 83% thereby clearly outperforming prediction based on the Gleason score. Moreover, we compared different machine learning algorithms to combine the most relevant phenes resulting in increased accuracies of 88% for tumor progression prediction. These findings will be of potential use for future prognostic tests for prostate cancer patients and provide a proof-of-principle of the Tissue Phenomics approach. Nature Publishing Group UK 2018-03-13 /pmc/articles/PMC5849604/ /pubmed/29535336 http://dx.doi.org/10.1038/s41598-018-22564-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Harder, Nathalie Athelogou, Maria Hessel, Harald Brieu, Nicolas Yigitsoy, Mehmet Zimmermann, Johannes Baatz, Martin Buchner, Alexander Stief, Christian G. Kirchner, Thomas Binnig, Gerd Schmidt, Günter Huss, Ralf Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer |
title | Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer |
title_full | Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer |
title_fullStr | Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer |
title_full_unstemmed | Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer |
title_short | Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer |
title_sort | tissue phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849604/ https://www.ncbi.nlm.nih.gov/pubmed/29535336 http://dx.doi.org/10.1038/s41598-018-22564-7 |
work_keys_str_mv | AT hardernathalie tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT athelogoumaria tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT hesselharald tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT brieunicolas tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT yigitsoymehmet tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT zimmermannjohannes tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT baatzmartin tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT buchneralexander tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT stiefchristiang tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT kirchnerthomas tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT binniggerd tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT schmidtgunter tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer AT hussralf tissuephenomicsforprognosticbiomarkerdiscoveryinlowandintermediateriskprostatecancer |